Table TDI-17. Route of administration by primary drug of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (vii) New hypnotics and sedatives outpatient clients by country and usual route of administration (%)

Country		Inject	Smoke/inhale	Eat/drink	Sniff	Others	Route known (n)	Route unknown
Belgium		1.2	0.0	98.8	0.0	0.0	83	3
Bulgaria		66.7	0.0	33.3	0.0	0.0	3	0
Czech Republic		0.0	11.1	88.9	0.0	0.0	9	0
Denmark		0.0	0.0	100.0	0.0	0.0	38	1
Germany		:	:	:	:	:	:	:
Estonia		:	:	:	:	:	:	:
Ireland		0.0	0.9	99.1	0.0	0.0	117	0
Greece		0.0	6.3	93.8	0.0	0.0	16	0
Spain	(1)	0.7	0.7	97.6	0.7	0.4	458	5
France		0.0	0.0	92.2	3.9	3.9	77	8
Italy		5.9	0.0	89.4	0.0	4.7	85	0
Cyprus		0.0	0.0	100.0	0.0	0.0	6	0
Latvia		0.0	2.9	94.3	2.9	0.0	35	1
Lithuania		0.0	0.0	100.0	0.0	0.0	6	0
Luxembourg		:	:	:	:	:	:	:
Hungary		0.0	0.0	82.6	17.4	0.0	23	0
Malta		:	:	:	:	:	:	:
Netherlands	(2)	0.5	2.2	96.7	0.5	0.0	182	31
Austria		0.0	0.0	100.0	0.0	0.0	39	0
Poland	(3)	0.0	0.0	72.7	0.0	27.3	44	1
Portugal		:	:	:	:	:	:	:
Romania		0.0	0.0	100.0	0.0	0.0	1	0
Slovenia		0.0	0.0	100.0	0.0	0.0	3	0
Slovakia		0.0	0.0	100.0	0.0	0.0	2	0
Finland		0.0	0.0	100.0	0.0	0.0	22	0
Sweden		0.0	0.0	100.0	0.0	0.0	123	0
United Kingdom		0.4	1.0	97.9	0.3	0.4	1143	43
Croatia		0.0	0.0	100.0	0.0	0.0	13	0
Turkey		:	:	:	:	:	:	:
Norway		:	:	:	:	:	:	:
Total		0.7	0.9	96.8	0.6	1.0	2528	93

Notes:

 : Indicates no data are available.                 

 Percentages are of clients whose route of administration is known (n) 

 (1) Data refer to 2008. Data refer to outpatient treatment centres and treatment units in prisons. 

 (2) Data refer to outpatient, inpatient and low-threshold agencies.                 

 (3) Data refers to 2008 and to 33 heatlh care units.                 

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2010 — TDI — outpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)